sector: Healthcare ·
industry: Pharmaceuticals - Diversified ·
As of
23 Nov 2009
1,277.50GBp
1,277.50p
23 Nov 2009
+1.91%
1,253.50p
1,262.00p
8,848,114
1,286.00p
1,259.00p
1,319.00p
982.00p
0.43
8,221,007
News
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Gent, Christopher |
Non-Executive Chairman of the Board |
651,000 |
| Witty, Andrew |
Chief Executive Officer, Executive Director |
1,778,000 |
| Heslop, Julian |
Chief Financial Officer, Executive Director |
926,000 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
£65,045.18 |
| Shares Outstanding (Mil.) |
5,189.08 |
| Float (Mil.) |
5,172.70 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend (£ GBP) |
0.57 |
| Payout Ratio(TTM) % |
62.13 |
| |
| Financial Strength |
| Quick Ratio |
1.32 |
| Current Ratio |
1.56 |
| LT Debt/Equity |
162.02 |
| Total Debt/Equity |
184.94 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
13.10 |
| Price/Sales(TTM) |
2.39 |
| Price/Book(TTM) |
7.01 |
| Price/Cash Flow(TTM) |
9.54 |
| |
|
| Per Share Data |
| Earnings(TTM) |
£0.96 |
| Sales(TTM) |
£5.33 |
| Book Value(MRQ) |
£1.79 |
| Cash Flow(TTM) |
£1.34 |
| Cash(MRQ) |
£1.35 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
58.25 |
| Return on Assets(TTM) |
13.33 |
| Return on Investment(TTM) |
18.34 |
| |
|
| Margins |
| Gross Margin(TTM) % |
75.39 |
| Operating Margin(TTM) % |
27.79 |
| Profit Margin(TTM) % |
18.46 |
|
| |
|